Cargando…

The Association Between Rate and Severity of Exacerbations in Chronic Obstructive Pulmonary Disease: An Application of a Joint Frailty-Logistic Model

Exacerbations are a hallmark of chronic obstructive pulmonary disease (COPD). Evidence suggests the presence of substantial between-individual variability (heterogeneity) in exacerbation rates. The question of whether individuals vary in their tendency towards experiencing severe (versus mild) exace...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sadatsafavi, Mohsen, Sin, Don D., Zafari, Zafar, Criner, Gerard, Connett, John E., Lazarus, Stephen, Han, Meilan, Martinez, Fernando, Albert, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Practice of Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100830/ https://www.ncbi.nlm.nih.gov/pubmed/27737842 http://dx.doi.org/10.1093/aje/kww085

Ejemplares similares

Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease
por: Hernández Cordero, Ana I., et al.
Publicado: (2021)

Mannose-binding lectin deficiency and acute exacerbations of chronic obstructive pulmonary disease
por: Albert, Richard K, et al.
Publicado: (2012)

Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
por: Ahmadian, Safa, et al.
Publicado: (2022)

Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)
por: Duffy, Sean, et al.
Publicado: (2017)

Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori
por: Ra, Seung Won, et al.
Publicado: (2017)

Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD
por: Leitao Filho, Fernando Sergio, et al.
Publicado: (2018)

Asymptotically Unbiased Estimation of Exposure Odds Ratios in Complete Records Logistic Regression
por: Bartlett, Jonathan W., et al.
Publicado: (2015)

Self-reported sleep quality and acute exacerbations of chronic obstructive pulmonary disease
por: Geiger-Brown, Jeanne, et al.
Publicado: (2015)

β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol
por: Bhatt, Surya P, et al.
Publicado: (2016)

Agreement Between 35 Published Frailty Scores in the General Population
por: Aguayo, Gloria A., et al.
Publicado: (2017)

Serum bilirubin and the risk of chronic obstructive pulmonary disease exacerbations
por: Brown, Kirstin E., et al.
Publicado: (2017)

A personalized biomedical risk assessment infographic for people who smoke with COPD: a qualitative study
por: Gupta, Samir, et al.
Publicado: (2022)

Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
por: Zafari, Zafar, et al.
Publicado: (2018)

A parametric model to jointly characterize rate, duration, and severity of exacerbations in episodic diseases
por: Safari, Abdollah, et al.
Publicado: (2023)

The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis - a case study of pharmacotherapies for moderate to severe COPD
por: Thorlund, Kristian, et al.
Publicado: (2014)

Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

ACCEPT 2·0: Recalibrating and externally validating the Acute COPD exacerbation prediction tool (ACCEPT)
por: Safari, Abdollah, et al.
Publicado: (2022)

Joint Modeling of Individual Trajectories, Within-Individual Variability, and a Later Outcome: Systolic Blood Pressure Through Childhood and Left Ventricular Mass in Early Adulthood
por: Parker, Richard M A, et al.
Publicado: (2020)

Characterizing undiagnosed chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Johnson, Kate M., et al.
Publicado: (2018)

Body mass index, waist circumference and pre-frailty/frailty: the Tromsø study 1994−2016
por: Uchai, Shreeshti, et al.
Publicado: (2023)

Use of biologics during pregnancy and risk of serious infections in the mother and baby: a Canadian population-based cohort study
por: Tsao, Nicole W, et al.
Publicado: (2019)

Modified generalized method of moments for a robust estimation of polytomous logistic model
por: Wang, Xiaoshan
Publicado: (2014)

Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study
por: Tan, W C, et al.
Publicado: (2014)

Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma
por: Zafari, Zafar, et al.
Publicado: (2016)

Estimating the Impact of Tuberculosis Case Detection in Constrained Health Systems: An Example of Case-Finding in South Africa
por: Sumner, Thomas, et al.
Publicado: (2019)

Comparability of Different Methods for Estimating Influenza Infection Rates Over a Single Epidemic Wave
por: Lee, Vernon J., et al.
Publicado: (2011)

Frailty in Chronic Obstructive Pulmonary Disease and Risk of Exacerbations and Hospitalizations
por: Yee, Nathan, et al.
Publicado: (2020)

Association between COPD exacerbations and lung function decline during maintenance therapy
por: Kerkhof, Marjan, et al.
Publicado: (2020)

An Empirical Approach to Defining Loss to Follow-up Among Patients Enrolled in Antiretroviral Treatment Programs
por: Chi, Benjamin H., et al.
Publicado: (2010)

The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology
por: Sadatsafavi, Mohsen, et al.
Publicado: (2018)

Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in Canada
por: Amegadzie, Joseph E., et al.
Publicado: (2023)

Time‐Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial
por: Dransfield, Mark T., et al.
Publicado: (2022)

The economics of precision health: preventing air pollution-induced exacerbation in asthma
por: Mohammadi, Tima, et al.
Publicado: (2021)

The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline
por: Nici, Linda, et al.
Publicado: (2020)

One-year mortality after severe COPD exacerbation in Bulgaria
por: Mekov, Evgeni, et al.
Publicado: (2016)

Heterogeneity's ruses: the neglected role of between-individual variability in longitudinal studies of COPD exacerbations
por: Sadatsafavi, Mohsen, et al.
Publicado: (2014)

Long-Term Natural History of Severe Asthma Exacerbations and Their Impact on the Disease Course
por: Lee, Tae Yoon, et al.
Publicado: (2022)

Cardiovascular disease risk scores in identifying future frailty: the Whitehall II prospective cohort study
por: Bouillon, Kim, et al.
Publicado: (2013)

Social and behavioural factors associated with frailty trajectories in a population-based cohort of older adults
por: Chamberlain, Alanna M, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s712k0ujinftqud8c7puigfck6